• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. COATED VICRYL; SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC ACID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. COATED VICRYL; SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC ACID Back to Search Results
Model Number VCP946H
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/12/2026
Type of Reportable Event Malfunction
Event or Problem Description
During cesarean section 0 vicryl ct-1 suture needle tip fractured off.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COATED VICRYL
Common Device Name
SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC ACID
Manufacturer (Section D)
ETHICON INC.
route 22 west, p.o. box 151
somerville NJ 08876
MDR Report Key24454806
Report Number24454806
Device Sequence Number9403439
Product Code GAM
UDI-Device Identifier10705031056145
UDI-Public(01)10705031056145
Combination Product (Y/N)N
Initial Reporter StateAZ
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type User Facility
Initial Reporter Occupation Risk Manager
Type of Report Initial
Report Date (Section B) 02/18/2026
Report Date (Section F) 02/18/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Model NumberVCP946H
Device Catalogue NumberVCP946H
Device Lot Number10BSXJ
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? Yes
Event Location Hospital
Date Report to Manufacturer02/26/2026
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date02/26/2026
Usage of Device Unknown
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexFemale
Date Report Sent to FDA02/18/2026
-
-